OLEMA ONCOLOGY

olema-oncology-logo

Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. The company focuses on the discovery, development, and commercialization of targeted therapies for women's cancers. It leverages the knowledge of the molecular action of the ER to design compounds that are superior to both the current drugs and those in development. Olema leverages their deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance with the goal of transforming the standard of care for pre- and post-menopausal women living with cancer by developing more convenient and effective therapies.

#SimilarOrganizations #People #Financial #Event #Website #More

OLEMA ONCOLOGY

Social Links:

Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical

Founded:
2007-01-01

Address:
San Francisco, California, United States

Country:
United States

Website Url:
http://www.olema.com

Total Employee:
11+

Status:
Active

Contact:
4157428265

Email Addresses:
[email protected]

Total Funding:
145.05 M USD

Technology used in webpage:
Google Font API Font Awesome Mobile Non Scaleable Content Nginx DigiCert SSL Digital Ocean RapidSSL Nginx 1.17


Similar Organizations

arcellx-logo

Arcellx

Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.

day-one-biopharmaceuticals-logo

Day One Biopharmaceuticals

Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.

novavax-logo

Novavax

Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.

pantheryx-logo

PanTheryx

PanTheryx is a nutrition and biotechnology company that utilizes the cellular and biomolecular processes of bovine colostrum.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.


Current Advisors List

gorjan-hrustanovic_image

Gorjan Hrustanovic Board Member @ Olema Oncology
Board_member
2020-07-01

frank-mccormick_image

Frank McCormick Board Member @ Olema Oncology
Board_member
2020-07-01

andy-rappaport_image

Andy Rappaport Board Member @ Olema Oncology
Board_member
2020-07-01

pamela-klein_image

Pamela Klein Senior Advisor @ Olema Oncology
Advisor
2022-01-01

yi-larson_image

Yi Larson Board Member @ Olema Oncology
Board_member
2021-01-01

graham-walmsley_image

Graham Walmsley Board Member @ Olema Oncology
Board_member

Current Employees Featured

shane-kovacs_image

Shane Kovacs
Shane Kovacs Chief Operating and Financial Officer @ Olema Oncology
Chief Operating and Financial Officer
2020-06-01

sean-bohen_image

Sean Bohen
Sean Bohen President and Chief Executive Officer @ Olema Oncology
President and Chief Executive Officer
2020-09-01

not_available_image

Peter Kushner
Peter Kushner Co-Founder and CSO @ Olema Oncology
Co-Founder and CSO

not_available_image

Jim Wagner
Jim Wagner Counsel @ Olema Oncology
Counsel
2020-11-01

john-moriarty_image

John Moriarty
John Moriarty Executive Vice President Chief Legal Officer and Corporate Secretary @ Olema Oncology
Executive Vice President Chief Legal Officer and Corporate Secretary
2020-09-01

naseem-zojwalla_image

Naseem Zojwalla
Naseem Zojwalla Chief Medical Officer @ Olema Oncology
Chief Medical Officer
2022-01-01

frank-mccormick_image

Frank McCormick
Frank McCormick Director @ Olema Oncology
Director
2014-12-01

cyrus-l-harmon_image

Cyrus L. Harmon
Cyrus L. Harmon Founder and CTO @ Olema Oncology
Founder and CTO
2020-09-01

Founder


cyrus-l-harmon_image

Cyrus L. Harmon

not_available_image

Peter Kushner

Stock Details


Company's stock symbol is NASDAQ:OLMA

Investors List

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series C - Olema Oncology

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series C - Olema Oncology

deerfield_image

Deerfield

Deerfield investment in Series C - Olema Oncology

avoro-capital-advisors_image

Avoro Capital Advisors

Avoro Capital Advisors investment in Series C - Olema Oncology

wellington-management_image

Wellington Management

Wellington Management investment in Series C - Olema Oncology

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series C - Olema Oncology

venrock_image

Venrock

Venrock investment in Series C - Olema Oncology

bvf-partners_image

BVF Partners

BVF Partners investment in Series C - Olema Oncology

logos-capital_image

Logos Capital

Logos Capital investment in Series C - Olema Oncology

vivo-capital_image

Vivo Capital

Vivo Capital investment in Series C - Olema Oncology

Key Employee Changes

Date New article
2022-01-31 Olema Oncology Appoints Naseem Zojwalla, M.D., as Chief Medical Officer

Official Site Inspections

http://www.olema.com Semrush global rank: 2.41 M Semrush visits lastest month: 7.51 K

  • Host name: 107.55.224.35.bc.googleusercontent.com
  • IP address: 35.224.55.107
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Olema Oncology" on Search Engine